Notice of Interim Results

RNS Number : 3662O

e-Therapeutics plc

19 September 2013

 

Notice of Interim Results

Oxford and Newcastle, UK, 19 September 2013- e-Therapeutics plc (AIM: ETX) will be announcing its interim results for the six months ended 31^st of July 2013 on Wednesday 16^th October 2013.

A group analyst briefing will be held at 09:30 GMT on 16^th October at Panmure Gordon & Co's offices at One New Change, London, EC4M 9AF. Analysts who wish to participate should contact Stefanie Bacher on [phone] or email [e-mail] to register.

- Ends -

For more information, please contact:

e-Therapeutics plc

Daniel Elger

Tel: [phone]

www.etherapeutics.co.uk 

Panmure Gordon (UK) Limited

Fred Walsh / Hannah Woodley / Grishma Patel

Tel: [phone]

www.panmure.com

College Hill

Melanie Toyne Sewell / Stefanie Bacher / Rebecca Caygill / Donia Al Saffar

Tel: [phone]

Email: [e-mail]

About e-Therapeutics

e-Therapeutics is an AIM-listed biotechnology company with a proprietary platform in network pharmacology, an innovative new approach to drug discovery based on advances in network science and chemical biology. The Company's discovery and development activity is focused in cancer and disorders of the nervous system. e-Therapeutics is based at sites in Oxford and Newcastle, UK. For more information about the Company please visit www.etherapeutics.co.uk.

 

END

 

 

NORSFDFWAFDSEEU